Fragment-based drug discovery (FBDD) has emerged as a rigorous and efficient strategy for identifying lead compounds against structurally defined biological ...
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
Ligand-based drug design is transforming pharmaceutical discovery by enabling researchers to identify promising therapeutics without requiring complete structural data on biological targets. Modern AI ...
Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies.
Pharos I Bio announced on July 24 that it has signed a memorandum of understanding (MOU) for joint research on AI-based new ...
When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer solutions that are not physically sound. Take, for example, AlphaFold, the AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results